Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

clonoSEQ identifies and quantifies DNA sequences in malignant cells—detecting one cancer cell in one million healthy cells—to help clinicians and researchers assess and monitor MRD with precision over ...

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...
PharmiWeb

Custom Antibody Market Size, Regional Outlook, Valuable Growth Factors, Business Strategies and Future Demand 2030

The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...
Taiwan News

U.S. Autoimmune Disease IVD & LDT Market to Reach USD 4.6B by 2033, Growing at a CAGR of 6.6%

The U.S. In Vitro Diagnostics (IVD) and Laboratory-Developed Tests (LDT) market for autoimmune diseases is set to witness transformative growth over the next decade. Valued at USD 2.51 billion in 2023 ...
Le Lézard

Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers

Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region's ...
Transparency Market Research

Antibody Specificity Testing Market

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...
IDA Ireland

IDA Ireland welcomes the publication of Government’s Accelerating Infrastructure Report and Action Plan

Enhancing Ireland’s Competitiveness: The Action Plan’s focus on streamlining planning, regulatory, and legal processes will ...
Le Lézard

Pet DNA Testing Market to Reach $960.7 Million, Globally, by 2034 at 9.3% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Pet DNA Testing Market by Animal Type (Dogs, Cats, and Others), Sample Type (Saliva, Blood, and Others), Test Type (Breed Profiles, Genetic Diseases ...
Morning Overview on MSN

Hidden mitochondrial DNA damage type uncovered by researchers

Mitochondrial DNA has long been treated as a workhorse record of cellular history, but new research suggests it also hides a subtle and previously overlooked form of damage. By uncovering this cryptic ...
European Medical Journal

Navigating a Dynamic Treatment Landscape: Established Therapies and Emerging Modalities for Patients with Lung Cancer

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
Science Daily

Next gen cancer drug shows surprising anti aging power

A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes ...
PharmiWeb

STD Diagnostics Market by Trends, Dynamic Innovation in Technology Key Players and Forecast to 2029

Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...